I guess I picked the wrong time to discover I'm a Romney Republican. Here for science (genetics, cell biology and cancer), parenting, comedy and random crap.
Today is the 40th anniversary of the publication of NEUROMANCER, William Gibson's (@GreatDismal) debut novel. Nobody asked me, but I've written an essay commemorating the occasion, complete with pretentious title. https://t.co/jGLzObnWnw
If you expect 10x return, then Isomorphic valuation is expected to be $500 billion. Only 3 Pharma companies have market cap that high: Eli Lilly, J&J and Abbvie and J&J is not just pharma, it’s consumer and diversified across medical decixes.
Isomorphic has no drugs and even if they got an IND now; none would be approved in next 7 years. You can’t speed up the evaluation of cancer, if your endpoint is PFS. Not due to regulatory delays; just biology. No amount of money or AI can shorten the evaluation of PFS.
They can’t sell their model as a SaaS b/c thats the whole supposedly unique R&D differentiation. Also, they could never be a $500 billion company off 1 model
Idk how things work, but it seems like it’s a tax write off of some kind.
I speak as someone who does not know very much about AI or Silicon Valley when I say that the entire industry deciding one guy who made a series of very very very stupid decisions is so important that we all just need to pretend those decisions didn't happen seems bad.
There was no need to wait for (mostly fake) social science “studies” to sanction getting the phones out of schools. Our collective experience of what screens do to our ability to sustain attention should have been more than sufficient to arrive at this conclusion years ago.
Part of the issue is that the chattering class is way too beholden to social science. A lot of people spent much of the last decade saying “there’s no evidence phones are the problem!” when we all have the lived experience of our phones zapping our attention and dumb-ifying us.
I haven’t lived here in awhile, but I see no other way to answer the hundreds of texts/DMs asking me if the world is, indeed, ending.
In the span of six days, we’ve experienced;
11/12 — Microsoft outage
11/13 — Nationwide FAA ground stop
11/16 — Major US banking disruptions
11/17 — NSA’s classified internal network goes down
We need far more analysis of why so much is breaking at once. I don’t want to get out over my skis here, and what I am hearing does not contradict the messaging that most of this is the result of screwy updates.
But stepping back, the dots are starting to form a collective picture. We are seeing:
• An explosion in severe and critical vulnerabilities, with AI accelerating discovery to 3X the number of vulnerabilities discovered in the same period last year. This is collectively being referred to as “vulnageddon” or “the vulnpocalypse.”
• Mean time to exploit those vulnerabilities has collapsed to NEGATIVE SEVEN DAYS. AI allows attackers to find/exploit vulns far faster than software makers have time to fix them.
• Powerful AI-enabled offensive tools like ARTEX have been thrown into the hands of every third tier nation state, cybercriminal and digital arsonist, which logically creates havoc.
• This creates enormous pressure to compress patching windows and accelerate software updates, increasing the likelihood these fixes break things in unexpected, cascading ways.
• Pressure to just “AI everything” means we are rolling out automated AI tooling on top of brittle infrastructure that can’t support it.
My generation grew up in an extraordinary period of technological stability. We worked our way up the software stack, abstracting away layer after layer, until we lost a fundamental understanding of how the underlying systems actually work.
We were told to “move fast and break things.” VCS told us to celebrate the idea that “software would eat the world.” Now we’re telling ourselves we can simply “roll out AI” across everything, as though nothing underneath will buckle.
We never stopped to ask: SHOULD WE?
Should we be digitizing every last nook and cranny of our companies, infrastructure, healthcare, homes, cars, bodies, lives? Especially when the complexity, interdependence, and fragility we were introducing overwhelmed our ability to understand/secure/maintain the systems we built?
Nobody every asked: What if, in the name of progress, we were creating the ripest attack surface in human history?
We are now entirely dependent on software systems that almost nobody understands end to end, that increasingly few people can repair, and that attackers can now probe at machine speed. We are hearing that incident response firms, the 911 for breach victims, are backlogged six months. Even those paid on retainer lack the bandwidth to triage every incident. The cavalry is disappearing.
We are entering a period of unprecedented technological instability.
“Software Beirut” is an incredibly apt analogy. We are in for a period of cascading failures, whether triggered by attackers, bad updates, or our own accumulated complexity.
This, I’m sorry to say, is just the opening chapter.
@hbolton completely retarded - there are women who have extreme difficulty carrying any pregnancy to term, due to recurrent miscarriage, are you saying that doctors should just treat the condition as equivalent to multiple elective abortions?
https://t.co/ZA5laLJNYu
Every story I read about AI feels like the most stereotypical 10th century Arabic depiction of dijin down to the "it does what you ask it but in its own escorterix way"
This is not about Gingko, but it used to be you don’t have your own lab; you’re not a real biotech. Now Isomorphic being praised for having no labs (they also have no drugs.) Virtual biotech is not new (15-20 years), but Isomorphic is unsuccessful at it.
“Staffing up for clinical trials.”
CROs are great, but seems like you need people that are or think like Basic Scientists / Translational Researchers to direct the labs or do experiments 👩🏻🔬
before you need people to run trials, which make more sense to be outsourced to Parexel or IQVIA, MedPace; PPD etc. then an AI x Bio company running clinical trials and not doing any translational research? 🧐
We all know they are fake job postings to make it seem like they’ll have clinical trials soon.
…Some think none until 2030.
Clair Health, a wearable company in the Bay Area, claims it could use skin surface level sensors with "AI and machine learning" to quantify women's four hormones: estradiol, progesterone, LH, and FSH. Since they raised over $11 million from VCs, they have completely changed their website, removed their thousand-word claims, and turned it into a multi-line FAQ.
Why? Because it is impossible. Quantifying hormone levels to match lab-level assays is not an AI/ML problem; it's a physics problem.
Because of the very low signal-to-noise ratio (SNR) on the skin surface for temperature, heart rate variability and electrodermal activities are already low enough. Adding on top the 100+ confounders that could affect hormone levels, the SNR for hormone signals on the skin level is exceptionally low.
Estimation theory and information theory would tell us that this level of SNR will not be able to provide inference-based quantification that would be remotely close to lab measurements.
This is not that different from Tesla's "Self-Driving" claims using vision-only cameras. Garbage in, garbage out. You cannot compute your way out of bad input information.
I have written a full article about it on LinkedIn. You can read it here.
This is another Theranos.
(Note that Clair Health has deleted its Threads account; however, it's still active as clair_health on Instagram).
Feels like we do this multiple times a month now:
* Winner of prestigious literature award caught by Pangram, work is AI-generated
* Author's community yells that Pangram results aren't reliable
* Pangram CEO guy offers money to people who can find a single proven false positive
* Nobody can find one
* Award committee puts out statement denying AI was used with no proof. Often with claims of racism, classism, etc.
* Run committee's statement through Pangram.
* It's AI generated
"There is 'more to announce in 2027' and will be 'hundreds of drugs.' Ok, why not just have 1 to start?"
This is why @MelindaBChu1 is my new favorite person on Twitter.
I can not quote tweet b/c he blocked me, but you should notice he put the words “accelerate” and “rapid” and “radically cut timelines” in his post. It’s been 5+ years. Your timelines are behind schedule especially for your funding.
There is nothing accelerated or rapid about Isomorphic’s progress in 5+ years. They do not have any human studies or even any specific preclinical data.
Milestone: Hassabis, Max and staff are able to sell a lot on the Secondaries though, so I guess that’s good for them.
To everyone, who said I’m dumb and they will def have human studies in 2026, there is “more to announce in 2027” and will be “hundreds of drugs”
Ok, why not just have 1 to start?